407.1K XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 20.83 per share. | 17 Mar 2025 | 12,500 | 990,392 | - | 20.8 | 260,320 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 21.44 per share. | 07 Mar 2025 | 6,667 | 323,310 | - | 21.4 | 142,936 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 04 Mar 2025 | 10,000 | 23,000 | - | 2.5 | 24,800 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 10,000 | 132,806 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 20.41 per share. | 27 Feb 2025 | 3,250 | 13,000 | - | 20.4 | 66,327 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 3,250 | 142,806 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 27 Feb 2025 | 3,250 | 16,250 | - | 2.5 | 8,060 | Common Stock |
| Lori Anne Kunkel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 15,368 | 15,368 | - | - | Stock Option (right to buy) | |
| Rishi Gupta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 20,491 | 20,491 | - | - | Stock Option (right to buy) | |
| Jacob Bauer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 20,491 | 20,491 | - | - | Stock Option (right to buy) | |
| Helen Collins | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 171,000 | 171,000 | - | - | Stock Option (right to buy) | |
| Rahul D. Ballal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 20,491 | 20,491 | - | - | Stock Option (right to buy) | |
| Andrew Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 20,491 | 20,491 | - | - | Stock Option (right to buy) | |
| Joseph P. Lyssikatos | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 171,000 | 171,000 | - | - | Stock Option (right to buy) | |
| Mika Derynck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 20,491 | 20,491 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 171,000 | 171,000 | - | - | Stock Option (right to buy) | |
| Anish Patel | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 171,000 | 171,000 | - | - | Stock Option (right to buy) | |
| Anish Patel | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 21.93 per share. | 06 Feb 2025 | 6,667 | 329,977 | - | 21.9 | 146,206 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 490,000 | 490,000 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 05 Feb 2025 | 1,000 | 14,000 | - | 2.5 | 2,480 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 22.52 per share. | 05 Feb 2025 | 1,000 | 13,000 | - | 22.5 | 22,524 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2025 | 1,000 | 146,056 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 27 Jan 2025 | 3,250 | 16,250 | - | 2.5 | 8,060 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 21.59 per share. | 27 Jan 2025 | 3,250 | 13,000 | - | 21.6 | 70,178 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2025 | 3,250 | 147,056 | - | - | Stock Option (right to buy) | |
| Anish Patel | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 24.15 per share. | 07 Jan 2025 | 20,260 | 1,440 | - | 24.2 | 489,330 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 24.56 per share. | 07 Jan 2025 | 1,440 | 0 | - | 24.6 | 35,368 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 24.17 per share. | 07 Jan 2025 | 6,577 | 336,734 | - | 24.2 | 158,957 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 07 Jan 2025 | 10,700 | 10,700 | - | 1.1 | 11,984 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2025 | 10,700 | 67 | - | - | Employee Stock Option (right to buy) | |
| Anish Patel | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2025 | 2,000 | 827 | - | - | Employee Stock Option (right to buy) | |
| Anish Patel | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2025 | 9,000 | 44,342 | - | - | Employee Stock Option (right to buy) | |
| Anish Patel | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 24.60 per share. | 07 Jan 2025 | 90 | 336,644 | - | 24.6 | 2,214 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 07 Jan 2025 | 2,000 | 12,700 | - | 2.5 | 4,960 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 07 Jan 2025 | 9,000 | 21,700 | - | 2.5 | 22,320 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 27 Dec 2024 | 3,350 | 3,350 | - | 2.5 | 8,308 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2024 | 900 | 164,306 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2024 | 3,350 | 165,206 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 22.51 per share. | 27 Dec 2024 | 900 | 0 | - | 22.5 | 20,255 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 27 Dec 2024 | 900 | 900 | - | 2.5 | 2,232 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 22.15 per share. | 27 Dec 2024 | 3,350 | 0 | - | 22.2 | 74,219 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2024 | 13,000 | 155,556 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2024 | 1,000 | 150,306 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 25.04 per share. | 13 Dec 2024 | 1,000 | 13,000 | - | 25.0 | 25,039 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 13 Dec 2024 | 1,000 | 14,000 | - | 2.5 | 2,480 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 13 Dec 2024 | 13,000 | 13,000 | - | 2.5 | 32,240 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 27 Nov 2024 | 5,250 | 5,250 | - | 2.5 | 13,020 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2024 | 5,250 | 168,556 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 25.38 per share. | 27 Nov 2024 | 1,000 | 0 | - | 25.4 | 25,376 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 24.78 per share. | 27 Nov 2024 | 4,250 | 1,000 | - | 24.8 | 105,313 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 28.49 per share. | 28 Oct 2024 | 5,600 | 650 | - | 28.5 | 159,562 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 28 Oct 2024 | 6,250 | 6,250 | - | 2.5 | 15,500 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 29.11 per share. | 28 Oct 2024 | 650 | 0 | - | 29.1 | 18,922 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2024 | 6,250 | 173,806 | - | - | Stock Option (right to buy) | |
| Helen Collins | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 18 Oct 2024 | 816 | 816 | - | 2.5 | 2,024 | Common Stock |
| Helen Collins | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Oct 2024 | 816 | 266,268 | - | - | Stock Option (right to buy) | |
| Helen Collins | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 18 Oct 2024 | 816 | 0 | - | 30.0 | 24,482 | Common Stock |
| Joseph P. Lyssikatos | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 18 Oct 2024 | 847 | 1,015,188 | - | 30.0 | 25,413 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Oct 2024 | 814 | 180,056 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 18 Oct 2024 | 814 | 814 | - | 2.5 | 2,019 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 18 Oct 2024 | 814 | 0 | - | 30.0 | 24,422 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 18 Oct 2024 | 716 | 343,311 | - | 30.0 | 21,483 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 18 Oct 2024 | 924 | 1,002,892 | - | 30.0 | 27,723 | Common Stock |
| Rahul D. Ballal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.68 per share. | 08 Oct 2024 | 6,314 | 28,655 | - | 19.7 | 124,260 | Common Stock |
| Rahul D. Ballal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2024 | 6,314 | 69,428 | - | - | Stock Option (right to buy) | |
| Rahul D. Ballal | Director | Sale of securities on an exchange or to another person at price $ 28.17 per share. | 08 Oct 2024 | 10,420 | 22,341 | - | 28.2 | 293,557 | Common Stock |
| Rahul D. Ballal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.52 per share. | 08 Oct 2024 | 4,106 | 32,761 | - | 5.5 | 22,665 | Common Stock |
| Rahul D. Ballal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2024 | 4,106 | 12,322 | - | - | Stock Option (right to buy) | |
| Joseph P. Lyssikatos | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 28.51 per share. | 08 Oct 2024 | 100 | 1,053,913 | - | 28.5 | 2,851 | Common Stock |
| Joseph P. Lyssikatos | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 28.52 per share. | 08 Oct 2024 | 3,589 | 1,016,035 | - | 28.5 | 102,358 | Common Stock |
| Joseph P. Lyssikatos | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 28.12 per share. | 08 Oct 2024 | 34,289 | 1,019,624 | - | 28.1 | 964,203 | Common Stock |
| Joseph P. Lyssikatos | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 27.96 per share. | 08 Oct 2024 | 13,167 | 1,054,013 | - | 28.0 | 368,173 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 28.51 per share. | 08 Oct 2024 | 100 | 1,020,526 | - | 28.5 | 2,851 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 28.53 per share. | 08 Oct 2024 | 2,830 | 1,003,816 | - | 28.5 | 80,730 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 28.07 per share. | 08 Oct 2024 | 13,880 | 1,006,646 | - | 28.1 | 389,675 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 27.95 per share. | 08 Oct 2024 | 13,167 | 1,020,626 | - | 28.0 | 368,078 | Common Stock |
| Joseph P. Lyssikatos | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 27.51 per share. | 04 Oct 2024 | 7,522 | 1,069,887 | - | 27.5 | 206,937 | Common Stock |
| Joseph P. Lyssikatos | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 27.61 per share. | 04 Oct 2024 | 2,707 | 1,067,180 | - | 27.6 | 74,727 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 1,270 | 180,870 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 04 Oct 2024 | 1,270 | 2,000 | - | 2.5 | 3,150 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 27.51 per share. | 04 Oct 2024 | 10,218 | 0 | - | 27.5 | 281,079 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 10,218 | 182,140 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 04 Oct 2024 | 10,218 | 10,218 | - | 2.5 | 25,341 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 27.51 per share. | 04 Oct 2024 | 1,270 | 0 | - | 27.5 | 34,935 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 27.51 per share. | 04 Oct 2024 | 12,206 | 1,036,523 | - | 27.5 | 335,792 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 27.50 per share. | 04 Oct 2024 | 2,730 | 1,033,793 | - | 27.5 | 75,075 | Common Stock |
| Joseph P. Lyssikatos | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 27.54 per share. | 01 Oct 2024 | 527 | 1,077,409 | - | 27.5 | 14,512 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 521 | 192,358 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 27.54 per share. | 01 Oct 2024 | 521 | 0 | - | 27.5 | 14,347 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 01 Oct 2024 | 521 | 521 | - | 2.5 | 1,292 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 27.54 per share. | 01 Oct 2024 | 526 | 1,048,729 | - | 27.5 | 14,485 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 27 Sep 2024 | 4,250 | 4,250 | - | 2.5 | 10,540 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Sep 2024 | 2,000 | 192,879 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Sep 2024 | 4,250 | 194,879 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 25.33 per share. | 27 Sep 2024 | 2,000 | 0 | - | 25.3 | 50,668 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 27 Sep 2024 | 2,000 | 2,000 | - | 2.5 | 4,960 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 24.27 per share. | 27 Sep 2024 | 4,250 | 0 | - | 24.3 | 103,161 | Common Stock |
| Joseph P. Lyssikatos | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 23.08 per share. | 29 Aug 2024 | 50 | 1,077,936 | - | 23.1 | 1,154 | Common Stock |
| Joseph P. Lyssikatos | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 22.48 per share. | 29 Aug 2024 | 11,950 | 1,077,986 | - | 22.5 | 268,687 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 22.54 per share. | 27 Aug 2024 | 4,250 | 0 | - | 22.5 | 95,782 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2024 | 4,250 | 199,129 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 27 Aug 2024 | 4,250 | 4,250 | - | 2.5 | 10,540 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 22.89 per share. | 26 Aug 2024 | 12,000 | 1,049,255 | - | 22.9 | 274,718 | Common Stock |
| Joseph P. Lyssikatos | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 27.56 per share. | 31 Jul 2024 | 3,099 | 1,089,936 | - | 27.6 | 85,399 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 31 Jul 2024 | 991 | 991 | - | 2.5 | 2,458 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2024 | 991 | 203,379 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 27.53 per share. | 31 Jul 2024 | 991 | 0 | - | 27.5 | 27,281 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 27.56 per share. | 31 Jul 2024 | 2,270 | 1,061,255 | - | 27.6 | 62,555 | Common Stock |
| Joseph P. Lyssikatos | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 26.69 per share. | 29 Jul 2024 | 11,797 | 1,093,238 | - | 26.7 | 314,809 | Common Stock |
| Joseph P. Lyssikatos | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 27.43 per share. | 29 Jul 2024 | 203 | 1,093,035 | - | 27.4 | 5,569 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 26.67 per share. | 29 Jul 2024 | 5,189 | 61 | - | 26.7 | 138,378 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 29 Jul 2024 | 5,250 | 5,250 | - | 2.5 | 13,020 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jul 2024 | 5,250 | 204,370 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 27.44 per share. | 29 Jul 2024 | 61 | 0 | - | 27.4 | 1,674 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 25.10 per share. | 25 Jul 2024 | 8,164 | 1,063,568 | - | 25.1 | 204,920 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 24.53 per share. | 25 Jul 2024 | 3,793 | 1,071,732 | - | 24.5 | 93,042 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 25.84 per share. | 25 Jul 2024 | 43 | 1,063,525 | - | 25.8 | 1,111 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jul 2024 | 3,000 | 209,620 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 25.06 per share. | 12 Jul 2024 | 3,000 | 0 | - | 25.1 | 75,195 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 12 Jul 2024 | 3,000 | 3,000 | - | 2.5 | 7,440 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 25.07 per share. | 12 Jul 2024 | 17,475 | 376,552 | - | 25.1 | 438,095 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 25.01 per share. | 12 Jul 2024 | 1,547 | 344,027 | - | 25.0 | 38,692 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 25.05 per share. | 12 Jul 2024 | 30,978 | 345,574 | - | 25.1 | 776,039 | Common Stock |
| Joseph P. Lyssikatos | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 22.89 per share. | 01 Jul 2024 | 12,000 | 1,105,035 | - | 22.9 | 274,736 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2024 | 4,250 | 212,620 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 27 Jun 2024 | 4,250 | 4,250 | - | 2.5 | 10,540 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 21.79 per share. | 27 Jun 2024 | 1,280 | 2,970 | - | 21.8 | 27,897 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 22.58 per share. | 27 Jun 2024 | 1,830 | 1,140 | - | 22.6 | 41,313 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 23.43 per share. | 27 Jun 2024 | 1,140 | 0 | - | 23.4 | 26,711 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 21.63 per share. | 25 Jun 2024 | 11,422 | 1,076,103 | - | 21.6 | 247,014 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 22.30 per share. | 25 Jun 2024 | 578 | 1,075,525 | - | 22.3 | 12,887 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2024 | 1,133 | 53,342 | - | - | Employee Stock Option (right to buy) | |
| Anish Patel | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 20.05 per share. | 06 Jun 2024 | 1,133 | 0 | - | 20.1 | 22,722 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 06 Jun 2024 | 1,133 | 1,133 | - | 2.5 | 2,810 | Common Stock |
| Joseph P. Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 29 May 2024 | 12,000 | 12,000 | - | 1.1 | 13,440 | Common Stock |
| Joseph P. Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 12,000 | 206,550 | - | - | Stock Option (right to buy) | |
| Joseph P. Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 22.52 per share. | 29 May 2024 | 2,123 | 0 | - | 22.5 | 47,813 | Common Stock |
| Joseph P. Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 21.56 per share. | 29 May 2024 | 9,877 | 2,123 | - | 21.6 | 212,988 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 28 May 2024 | 4,250 | 4,250 | - | 2.5 | 10,540 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 4,250 | 216,870 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 24.30 per share. | 28 May 2024 | 10 | 0 | - | 24.3 | 243 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 23.42 per share. | 28 May 2024 | 2,334 | 10 | - | 23.4 | 54,659 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 22.89 per share. | 28 May 2024 | 1,906 | 2,344 | - | 22.9 | 43,628 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 24.34 per share. | 28 May 2024 | 100 | 0 | - | 24.3 | 2,434 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 23.57 per share. | 28 May 2024 | 5,219 | 100 | - | 23.6 | 123,020 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 22.86 per share. | 28 May 2024 | 6,681 | 5,319 | - | 22.9 | 152,756 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 28 May 2024 | 12,000 | 12,000 | - | 1.1 | 13,440 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 12,000 | 188,841 | - | - | Stock Option (right to buy) | |
| Rishi Gupta | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 22.14 per share. | 16 May 2024 | 1,000,000 | 7,663,349 | - | 22.1 | 22,140,000 | Common Stock |
| Rishi Gupta | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 22.14 per share. | 16 May 2024 | 33,300 | 254,814 | - | 22.1 | 737,262 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 14 May 2024 | 1,107 | 1,107 | - | 2.5 | 2,745 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2024 | 1,107 | 54,475 | - | - | Employee Stock Option (right to buy) | |
| Anish Patel | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 14 May 2024 | 1,107 | 0 | - | 25 | 27,675 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 09 May 2024 | 260 | 260 | - | 2.5 | 645 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 25.06 per share. | 09 May 2024 | 260 | 0 | - | 25.1 | 6,515 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 260 | 55,582 | - | - | Employee Stock Option (right to buy) | |
| Anish Patel | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 22.72 per share. | 06 May 2024 | 4,875 | 0 | - | 22.7 | 110,769 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 4,875 | 55,842 | - | - | Employee Stock Option (right to buy) | |
| Anish Patel | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 06 May 2024 | 4,875 | 4,875 | - | 2.5 | 12,090 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 03 May 2024 | 1,000 | 1,000 | - | 2.5 | 2,480 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 22.50 per share. | 03 May 2024 | 1,000 | 0 | - | 22.5 | 22,500 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 1,000 | 221,120 | - | - | Stock Option (right to buy) | |
| Joseph P. Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 29 Apr 2024 | 12,000 | 12,000 | - | 1.1 | 13,440 | Common Stock |
| Joseph P. Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2024 | 12,000 | 218,550 | - | - | Stock Option (right to buy) | |
| Joseph P. Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 18.48 per share. | 29 Apr 2024 | 1,013 | 0 | - | 18.5 | 18,723 | Common Stock |
| Joseph P. Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 17.86 per share. | 29 Apr 2024 | 10,987 | 1,013 | - | 17.9 | 196,265 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2024 | 3,250 | 222,120 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 29 Apr 2024 | 3,250 | 3,250 | - | 2.5 | 8,060 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 16.97 per share. | 29 Apr 2024 | 3,250 | 0 | - | 17.0 | 55,165 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 25 Apr 2024 | 12,000 | 12,000 | - | 1.1 | 13,440 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 16.89 per share. | 25 Apr 2024 | 12,000 | 0 | - | 16.9 | 202,700 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2024 | 12,000 | 200,841 | - | - | Stock Option (right to buy) | |
| Helen Collins | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 11 Apr 2024 | 20,000 | 20,000 | - | 2.5 | 49,600 | Common Stock |
| Helen Collins | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 20,000 | 267,084 | - | - | Stock Option (right to buy) | |
| Helen Collins | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 25.07 per share. | 11 Apr 2024 | 20,000 | 0 | - | 25.1 | 501,478 | Common Stock |
| Joseph P. Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 30,000 | 230,550 | - | - | Stock Option (right to buy) | |
| Joseph P. Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 25.04 per share. | 11 Apr 2024 | 30,000 | 0 | - | 25.0 | 751,332 | Common Stock |
| Joseph P. Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 11 Apr 2024 | 30,000 | 30,000 | - | 1.1 | 33,600 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 25.04 per share. | 11 Apr 2024 | 10,223 | 0 | - | 25.0 | 255,970 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 14,000 | 225,370 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 23.88 per share. | 11 Apr 2024 | 3,777 | 10,223 | - | 23.9 | 90,179 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 11 Apr 2024 | 14,000 | 14,000 | - | 2.5 | 34,720 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 11 Apr 2024 | 17,500 | 0 | - | 25.0 | 438,099 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 11 Apr 2024 | 14,903 | 17,500 | - | 2.5 | 36,959 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 14,903 | 60,717 | - | - | Employee Stock Option (right to buy) | |
| Samuel Kintz | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 47,709 | 212,841 | - | - | Stock Option (right to buy) | |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 25.04 per share. | 11 Apr 2024 | 47,709 | 0 | - | 25.0 | 1,194,700 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 11 Apr 2024 | 47,709 | 47,709 | - | 1.1 | 53,434 | Common Stock |
| Rahul D. Ballal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.60 per share. | 10 Apr 2024 | 13,600 | 35,941 | - | 12.6 | 171,360 | Common Stock |
| Rahul D. Ballal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2024 | 4,580 | 75,742 | - | - | Stock Option (right to buy) | |
| Rahul D. Ballal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2024 | 48,820 | 0 | - | - | Stock Option (right to buy) | |
| Rahul D. Ballal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2024 | 13,600 | 48,820 | - | - | Stock Option (right to buy) | |
| Rahul D. Ballal | Director | Sale of securities on an exchange or to another person at price $ 25.21 per share. | 10 Apr 2024 | 3,068 | 22,341 | - | 25.2 | 77,342 | Common Stock |
| Rahul D. Ballal | Director | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 10 Apr 2024 | 20,032 | 25,409 | - | 25.0 | 500,702 | Common Stock |
| Rahul D. Ballal | Director | Sale of securities on an exchange or to another person at price $ 23.14 per share. | 10 Apr 2024 | 30,300 | 45,441 | - | 23.1 | 701,024 | Common Stock |
| Rahul D. Ballal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.68 per share. | 10 Apr 2024 | 4,580 | 75,741 | - | 19.7 | 90,134 | Common Stock |
| Rahul D. Ballal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.60 per share. | 10 Apr 2024 | 48,820 | 71,161 | - | 12.6 | 615,132 | Common Stock |
| Rahul D. Ballal | Director | Sale of securities on an exchange or to another person at price $ 21.01 per share. | 10 Apr 2024 | 13,600 | 22,341 | - | 21.0 | 285,744 | Common Stock |
| Lori Anne Kunkel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2024 | 37,882 | 37,882 | - | - | Stock Option (right to buy) | |
| Anish Patel | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 19.40 per share. | 08 Apr 2024 | 544 | 2,597 | - | 19.4 | 10,552 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 18.50 per share. | 08 Apr 2024 | 4,331 | 3,141 | - | 18.5 | 80,134 | Common Stock |
| Rahul D. Ballal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.60 per share. | 04 Apr 2024 | 3,485 | 25,826 | - | 12.6 | 43,911 | Common Stock |
| Rahul D. Ballal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2024 | 3,485 | 62,420 | - | - | Stock Option (right to buy) | |
| Rahul D. Ballal | Director | Sale of securities on an exchange or to another person at price $ 19.15 per share. | 04 Apr 2024 | 3,485 | 22,341 | - | 19.1 | 66,729 | Common Stock |
| Rahul D. Ballal | Director | Sale of securities on an exchange or to another person at price $ 19.08 per share. | 01 Apr 2024 | 3,237 | 22,341 | - | 19.1 | 61,758 | Common Stock |
| Rahul D. Ballal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 94 | 65,905 | - | - | Stock Option (right to buy) | |
| Rahul D. Ballal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 3,143 | 16,428 | - | - | Stock Option (right to buy) | |
| Rahul D. Ballal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.60 per share. | 01 Apr 2024 | 94 | 22,435 | - | 12.6 | 1,184 | Common Stock |
| Rahul D. Ballal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.52 per share. | 01 Apr 2024 | 3,143 | 25,578 | - | 5.5 | 17,349 | Common Stock |
| Joseph P. Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 18.80 per share. | 01 Apr 2024 | 9,577 | 71 | - | 18.8 | 180,084 | Common Stock |
| Joseph P. Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 17.72 per share. | 01 Apr 2024 | 2,352 | 9,648 | - | 17.7 | 41,687 | Common Stock |
| Joseph P. Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 01 Apr 2024 | 12,000 | 12,000 | - | 1.1 | 13,440 | Common Stock |
| Joseph P. Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 12,000 | 260,550 | - | - | Stock Option (right to buy) | |
| Joseph P. Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 19.35 per share. | 01 Apr 2024 | 71 | 0 | - | 19.4 | 1,374 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 25 Mar 2024 | 12,000 | 12,000 | - | 1.1 | 13,440 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2024 | 12,000 | 260,550 | - | - | Stock Option (right to buy) | |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 18.16 per share. | 25 Mar 2024 | 4,671 | 0 | - | 18.2 | 84,841 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 17.17 per share. | 25 Mar 2024 | 7,329 | 4,671 | - | 17.2 | 125,820 | Common Stock |
| Rahul D. Ballal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 13,278 | 19,571 | - | - | Stock Option (right to buy) | |
| Rahul D. Ballal | Director | Sale of securities on an exchange or to another person at price $ 19.16 per share. | 20 Mar 2024 | 13,278 | 22,341 | - | 19.2 | 254,462 | Common Stock |
| Rahul D. Ballal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.52 per share. | 20 Mar 2024 | 13,278 | 35,619 | - | 5.5 | 73,295 | Common Stock |
| Anish Patel | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 15.64 per share. | 06 Mar 2024 | 4,875 | 7,472 | - | 15.6 | 76,239 | Common Stock |
| Joseph P. Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 29 Feb 2024 | 12,000 | 12,000 | - | 1.1 | 13,440 | Common Stock |
| Joseph P. Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 12,000 | 272,550 | - | - | Stock Option (right to buy) | |
| Joseph P. Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 17.09 per share. | 29 Feb 2024 | 1,805 | 0 | - | 17.1 | 30,854 | Common Stock |
| Joseph P. Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 16.30 per share. | 29 Feb 2024 | 10,195 | 1,805 | - | 16.3 | 166,152 | Common Stock |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 16.97 per share. | 27 Feb 2024 | 3,250 | 0 | - | 17.0 | 55,163 | Common Stock |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 27 Feb 2024 | 3,250 | 3,250 | - | 2.5 | 8,060 | Common Stock |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 3,250 | 242,620 | - | - | Stock Option (right to buy) | |
| Kintz Samuel | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 26 Feb 2024 | 12,000 | 12,000 | - | 1.1 | 13,440 | Common Stock |
| Kintz Samuel | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 17.24 per share. | 26 Feb 2024 | 4,376 | 0 | - | 17.2 | 75,435 | Common Stock |
| Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 16.69 per share. | 26 Feb 2024 | 7,624 | 4,376 | - | 16.7 | 127,219 | Common Stock |
| Kintz Samuel | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 12,000 | 272,550 | - | - | Stock Option (right to buy) | |
| Samuel Kintz | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 410,000 | 410,000 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 185,000 | 185,000 | - | - | Stock Option (right to buy) | |
| Jake Bauer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 23,364 | 23,364 | - | - | Stock Option (right to buy) | |
| D. Rahul Ballal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 23,364 | 23,364 | - | - | Stock Option (right to buy) | |
| Phillips Andrew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 23,364 | 23,364 | - | - | Stock Option (right to buy) | |
| Joseph Lyssikatos P. | Director, CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 185,000 | 185,000 | - | - | Stock Option (right to buy) | |
| Rishi Gupta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 23,364 | 23,364 | - | - | Stock Option (right to buy) | |
| Mika Derynck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 23,364 | 23,364 | - | - | Stock Option (right to buy) | |
| Anish Patel | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 185,000 | 185,000 | - | - | Stock Option (right to buy) | |
| Collins Helen | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 185,000 | 185,000 | - | - | Stock Option (right to buy) | |
| Anish Patel | CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 15.11 per share. | 06 Feb 2024 | 4,875 | 12,347 | - | 15.1 | 73,658 | Common Stock |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 3,250 | 245,870 | - | - | Stock Option (right to buy) | |
| P. Joseph Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 15.85 per share. | 29 Jan 2024 | 12,000 | 0 | - | 15.9 | 190,256 | Common Stock |
| P. Joseph Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 12,000 | 284,550 | - | - | Stock Option (right to buy) | |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 29 Jan 2024 | 3,250 | 3,250 | - | 2.5 | 8,060 | Common Stock |
| Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 15.81 per share. | 29 Jan 2024 | 3,250 | 0 | - | 15.8 | 51,388 | Common Stock |
| P. Joseph Lyssikatos | Director, CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 29 Jan 2024 | 12,000 | 12,000 | - | 1.1 | 13,440 | Common Stock |
| Kintz Samuel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.89 per share. | 25 Jan 2024 | 9,458 | 0 | - | 15.9 | 150,257 | Common Stock |
| Kintz Samuel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 25 Jan 2024 | 12,000 | 12,000 | - | 1.1 | 13,440 | Common Stock |
| Samuel Kintz | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 14.94 per share. | 25 Jan 2024 | 2,542 | 9,458 | - | 14.9 | 37,972 | Common Stock |
| Kintz Samuel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2024 | 12,000 | 284,550 | - | - | Stock Option (right to buy) | |
| Patel Anish | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.13 per share. | 22 Jan 2024 | 4,875 | 17,222 | - | 15.1 | 73,783 | Common Stock |
| Joseph P. Lyssikatos | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 29 Dec 2023 | 12,000 | 12,000 | - | 1.1 | 13,440 | Common Stock |
| Lyssikatos P. Joseph | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.78 per share. | 29 Dec 2023 | 2,849 | 0 | - | 14.8 | 42,113 | Common Stock |
| Joseph P. Lyssikatos | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2023 | 12,000 | 296,550 | - | - | Stock Option (right to buy) | |
| P. Joseph Lyssikatos | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.13 per share. | 29 Dec 2023 | 9,151 | 2,849 | - | 14.1 | 129,268 | Common Stock |
| Anish Patel | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.08 per share. | 28 Dec 2023 | 2,520 | 33,117 | - | 15.1 | 37,996 | Common Stock |
| Hohl Benjamin | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2023 | 9,383 | 249,120 | - | - | Employee Stock Option (right to buy) | |
| Benjamin Hohl | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2023 | 2,467 | 258,523 | - | - | Employee Stock Option (right to buy) | |
| Benjamin Hohl | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 28 Dec 2023 | 9,383 | 9,383 | - | 2.5 | 23,270 | Common Stock |
| Benjamin Hohl | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 28 Dec 2023 | 20 | 0 | - | 15 | 300 | Common Stock |
| Patel Anish | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 28 Dec 2023 | 11,000 | 22,097 | - | 15.0 | 165,053 | Common Stock |
| Hohl Benjamin | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.07 per share. | 28 Dec 2023 | 2,467 | 0 | - | 15.1 | 37,188 | Common Stock |
| Patel Anish | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 28 Dec 2023 | 20 | 33,097 | - | 15 | 300 | Common Stock |
| Hohl Benjamin | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2023 | 20 | 258,503 | - | - | Employee Stock Option (right to buy) | |
| Benjamin Hohl | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 28 Dec 2023 | 9,383 | 0 | - | 15.0 | 140,839 | Common Stock |
| Hohl Benjamin | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 28 Dec 2023 | 2,467 | 2,467 | - | 2.5 | 6,118 | Common Stock |
| Hohl Benjamin | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 28 Dec 2023 | 20 | 20 | - | 2.5 | 50 | Common Stock |
| Kintz Samuel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Dec 2023 | 12,000 | 296,550 | - | - | Stock Option (right to buy) | |
| Kintz Samuel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 26 Dec 2023 | 12,000 | 12,000 | - | 1.1 | 13,440 | Common Stock |
| Samuel Kintz | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 14.64 per share. | 26 Dec 2023 | 12,000 | 0 | - | 14.6 | 175,709 | Common Stock |
| Anish Patel | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 22 Dec 2023 | 102 | 35,637 | - | 15.0 | 1,531 | Common Stock |
| Hohl Benjamin | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 22 Dec 2023 | 1,030 | 1,030 | - | 2.5 | 2,554 | Common Stock |
| Hohl Benjamin | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 22 Dec 2023 | 100 | 100 | - | 2.5 | 248 | Common Stock |
| Benjamin Hohl | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.07 per share. | 22 Dec 2023 | 1,030 | 0 | - | 15.1 | 15,525 | Common Stock |
| Patel Anish | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.03 per share. | 22 Dec 2023 | 983 | 35,739 | - | 15.0 | 14,776 | Common Stock |
| Benjamin Hohl | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2023 | 1,030 | 261,090 | - | - | Employee Stock Option (right to buy) | |
| Benjamin Hohl | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2023 | 100 | 260,990 | - | - | Employee Stock Option (right to buy) | |
| Benjamin Hohl | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 22 Dec 2023 | 100 | 0 | - | 15 | 1,500 | Common Stock |
| Lyssikatos Joseph P. | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 21 Dec 2023 | 20 | 0 | - | 13 | 260 | Common Stock |
| Samuel Kintz | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.05 per share. | 21 Dec 2023 | 8,175 | 0 | - | 13.0 | 106,655 | Common Stock |
| Kintz Samuel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2023 | 8,175 | 308,550 | - | - | Stock Option (right to buy) | |
| P. Lyssikatos Joseph | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.07 per share. | 21 Dec 2023 | 6,546 | 0 | - | 13.1 | 85,530 | Common Stock |
| P. Lyssikatos Joseph | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 21 Dec 2023 | 6,546 | 6,546 | - | 1.1 | 7,332 | Common Stock |
| Samuel Kintz | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 21 Dec 2023 | 20 | 0 | - | 13 | 260 | Common Stock |
| Lyssikatos Joseph P. | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2023 | 6,546 | 308,550 | - | - | Stock Option (right to buy) | |
| Lyssikatos Joseph P. | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2023 | 20 | 315,096 | - | - | Stock Option (right to buy) | |
| Joseph Lyssikatos P. | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.10 per share. | 21 Dec 2023 | 20 | 20 | - | 1.1 | 22 | Common Stock |
| Kintz Samuel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 21 Dec 2023 | 8,175 | 8,175 | - | 1.1 | 9,156 | Common Stock |
| Samuel Kintz | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2023 | 20 | 316,725 | - | - | Stock Option (right to buy) | |
| Kintz Samuel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.10 per share. | 21 Dec 2023 | 20 | 20 | - | 1.1 | 22 | Common Stock |
| Kintz Samuel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 13.01 per share. | 20 Dec 2023 | 7,779 | 0 | - | 13.0 | 101,238 | Common Stock |
| Samuel Kintz | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2023 | 7,779 | 316,745 | - | - | Stock Option (right to buy) | |
| Samuel Kintz | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 20 Dec 2023 | 7,779 | 7,779 | - | 1.1 | 8,712 | Common Stock |
| Lyssikatos P. Joseph | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 19 Dec 2023 | 200 | 200 | - | 1.1 | 224 | Common Stock |
| Lyssikatos Joseph P. | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 200 | 323,804 | - | - | Stock Option (right to buy) | |
| Joseph P. Lyssikatos | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 19 Dec 2023 | 200 | 0 | - | 13 | 2,600 | Common Stock |
| Joseph Lyssikatos P. | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 8,688 | 315,116 | - | - | Stock Option (right to buy) | |
| P. Joseph Lyssikatos | Director, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.12 per share. | 19 Dec 2023 | 8,688 | 8,688 | - | 1.1 | 9,731 | Common Stock |
| Lyssikatos Joseph P. | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.01 per share. | 19 Dec 2023 | 8,688 | 0 | - | 13.0 | 113,046 | Common Stock |
| Rishi Gupta | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 2,125 | 0 | - | - | Stock Options (Right to Buy) | |
| Rishi Gupta | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.28 per share. | 17 May 2023 | 2,125 | 8,663,349 | - | 4.3 | 9,095 | Common Stock |
| Helen Collins | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 206,000 | 206,000 | - | - | Stock Option (right to buy) | |
| Joseph P. Lyssikatos | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 206,000 | 206,000 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 206,000 | 206,000 | - | - | Stock Option (right to buy) | |
| Anish Patel | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 206,000 | 206,000 | - | - | Stock Option (right to buy) | |
| Samuel Kintz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 452,000 | 452,000 | - | - | Stock Option (right to buy) | |
| Rishi Gupta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 7,611,458 | 7,611,458 | - | - | Common Stock | |
| Rishi Gupta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 288,114 | 288,114 | - | - | Common Stock | |
| Rishi Gupta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 27,567 | 27,567 | - | - | Stock Option (right to buy) | |
| Andrew J. Schwab | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 4,838,092 | 4,838,092 | - | - | Common Stock | |
| Andrew J. Schwab | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 27,567 | 27,567 | - | - | Stock Option (right to buy) | |
| Andrew J. Schwab | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 960,383 | 960,383 | - | - | Common Stock | |
| Jake Bauer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 87,372 | 87,372 | - | - | Common Stock | |
| Jake Bauer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 17,706 | 17,706 | - | - | Stock Option | |
| Jake Bauer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 27,567 | 27,567 | - | - | Stock Option (right to buy) | |
| Helen Collins | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 287,084 | 287,084 | - | - | Employee Stock Option (right to buy) | |
| Rahul D. Ballal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 27,567 | 27,567 | - | - | Stock Option (right to buy) | |
| Andrew Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 27,567 | 27,567 | - | - | Stock Option (right to buy) | |
| Joseph P. Lyssikatos | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 344,550 | 344,550 | - | - | Employee Stock Option (right to buy) | |
| Joseph P. Lyssikatos | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 88,531 | 88,531 | - | - | Employee Stock Option (right to buy) | |
| Joseph P. Lyssikatos | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 1,117,035 | 1,117,035 | - | - | Common Stock | |
| Mika Derynck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 87,373 | 87,373 | - | - | Employee Stock Option (right to buy) | |
| Mika Derynck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 27,567 | 27,567 | - | - | Stock Option (right to buy) | |
| Benjamin Hohl | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 262,120 | 262,120 | - | - | Employee Stock Option (right to buy) | |
| Anish Patel | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 36,722 | 36,722 | - | - | Common Stock | |
| Anish Patel | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 10,767 | 10,767 | - | - | Employee Stock Option (right to buy) | |
| Anish Patel | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 2,827 | 2,827 | - | - | Employee Stock Option (right to buy) | |
| Anish Patel | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 75,620 | 75,620 | - | - | Employee Stock Option (right to buy) | |
| Anish Patel | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 394,027 | 394,027 | - | - | Common Stock | |
| Samuel Kintz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 404,363 | 404,363 | - | - | Employee Stock Option (right to buy) | |
| Samuel Kintz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 344,550 | 344,550 | - | - | Employee Stock Option (right to buy) | |
| Samuel Kintz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 88,531 | 88,531 | - | - | Common Stock | |
| Samuel Kintz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 88,531 | 88,531 | - | - | Common Stock | |
| Samuel Kintz | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 1,087,525 | 1,087,525 | - | - | Common Stock |